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Abstract. Matrix metalloproteinases (MMPs) exhibit an 
important function in extracellular matrix degradation. MMPs 
modulate the activation of growth factors, cytokines and 
metastasis. At present, the effect of exercise on serum levels of 
MMP-2 and -9 remains unclear. The aim of the present study 
was to investigate the effect of various physical activities on 
the circulating levels of MMP-2 and -9 in breast cancer (BC) 
survivors and healthy subjects. A total of 66 female subjects 
were enrolled in the present study. The cohort included 46 BC 
survivors and 20 healthy subjects divided into 5 groups: 
Group A (17 BC survivors, participating in recreational 
dragon boat paddling), group B (14 BC survivors, participating 
in recreational physical activity), group C (15 sedentary BC 
survivors), group D (10 healthy subjects, participating in 
recreational physical activity) and group E (10 sedentary 
healthy subjects). ELISA assays revealed a significant increase 
in the level of circulating MMP-2 in group B compared with 
all other groups. Recreational physical activity increased the 
levels of MMP-9 in healthy subjects (group D vs. E), however, 
the differences were not statistically significant, while in the 
BC survivor groups the results were opposite, with exercise 
reducing MMP-9 levels (group B vs. C). Furthermore, a 
significant increase in MMP-2 was observed in group B 
lymph node metastasis-positive (N+) subjects compared with 
group A and C N+ subjects. Thus, the results of the present 
study indicate that various physical activities modulate the 
levels of circulating MMP-2 and -9 in BC survivors, and the 
same exercise program induces a different effect when under-
taken by healthy subjects and BC survivors. These results 
may have important implications with regard to the selection 
of appropriate physical activities for BC survivors, leading to 
improvements to their survival and prevention of recurrence, 
as well as amelioration of physical function, quality of life and 
fatigue.
Introduction
Breast cancer (BC) is the most common malignancy in women 
worldwide. Novel breast cancer cases and cancer-associated 
mortalities accounted for 29 and 15%, respectively, of all 
female cancers in 2015 (1). Lifestyle is considered an impor-
tant risk factor for BC. All types of physical activity appear to 
reduce the risk of BC, although the evidence of this association 
is stronger for BC occurring in post-menopausal women than 
pre-menopausal women (2,3).
Studies have shown that the risk of BC is ~25% lower 
in the most active trained women compared with sedentary 
women (4,5). The BC risk is 17% higher in sedentary women 
compared with women that perform physical activity (6). In 
addition, the risk of BC decreases by 5% for every 2 h per 
week in women performing moderate or vigorous recreational 
activity (7). Physical activity has also been demonstrated 
to reduce the risk of BC recurrence in BC survivors (8,9). 
Therefore, The American Cancer Society recommends that 
cancer survivors partake in 150 min of physical activity per 
week (10,11).
The mechanism underlying the health benefits of regular 
exercise may involve the cumulative anti-inflammatory 
effects of repeated physical exercise (12,13). Regular exercise 
promotes the synthesis of myokines that modulate the inflam-
matory response (14). In addition, exercise may affect the 
levels of matrix metalloproteinases (MMPs) (15,16).
MMPs are a family of structurally and functionally related 
proteinases that are characterized by their ability to degrade 
the extracellular matrix (ECM), and their involvement in 
the normal functioning of various tissues during growth, 
development and aging (16,17). MMP expression is induced 
by a number of factors, including inflammatory cytokines, 
hormones, growth factors and oncogenes (18,19). In addition, 
MMPs are implicated in tumor invasion and metastasis (20,21). 
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MMP-2 and -9 have been reported to exhibit an important ECM 
homeostatic function during muscle growth, development and 
repair processes (16). Previous studies have demonstrated that 
physical exercise affects the levels of MMPs following acute 
and chronic therapies in humans (22-24). A marginal increase 
in MMP-9, but not MMP-2, serum concentration has been 
demonstrated to occur following acute physical exercise (25). 
In particular, MMP-2 and -9 serum levels increase following 
exercise training that incorporates resistance-type exercise, 
as the mechanical stressors result in ECM remodeling (26). 
MMP-2 and -9 hydrolyze components of the basement 
membrane, and regulate tumor growth and metastasis (27). 
Activated MMP-2 is located in the protruding section of the 
cell-penetrating matrix. Its activation facilitates the passage of 
tumor cells through the ECM and the basal membrane of the 
blood vessel wall, thus promoting invasion of tumor cells (28). 
In addition, MMP-2 and -9 are gelatinases; thus, their role 
in the degradation of gelatin leads to the release of signaling 
molecules from the ECM that aid cell migration and angio-
genesis (29). Previous studies have investigated the effects 
of acute short duration exercise on MMP concentrations 
in skeletal muscle and plasma (30,31). However, it remains 
unclear whether different exercise training programs promote 
different MMP responses (32). To the best of our knowledge, 
no previous studies have investigated the effect of exercise on 
the modulation of MMP-2 or -9 serum concentration in BC 
survivors.
In our previous study, it was demonstrated that 
muscle-derived cytokines are released following a dragon boat 
training program and the resulting decreased oxidative stress 
conditions are responsible for the health benefits observed in 
patients with BC (14). In the present study, the effect of two 
different exercise training programs on MMP-2 and -9 serum 
concentration was investigated in BC survivors and healthy 
subjects. In addition, the association between MMP serum 
concentration and lymph node metastasis was investigated in 
BC survivors. The patients enrolled in the current study were 
active individuals involved in dragon boat paddling or other 
recreational physical activities.
Dragon boat paddling is a competitive sport that originated 
in China >2,000 years ago (33). Dragon boat paddling is a 
repetitive, vigorous physical exercise that increases flexibility, 
aerobic capacity and strength, and provides a novel approach 
for upper body rehabilitation following breast surgery and 
radiation treatment. This exercise has been reported to reduce 
the risk of developing lymphedema in women at the highest 
risk by 70% (34).
The present study may have important implications for BC 
survivors, with regard to their lifestyle choices and participa-
tion in physical activity.
Patients and methods
Patients. A total of 66 women were enrolled in the present 
study, between May and December 2014, in collaboration with 
Associazione Pagaie Rosa Dragon Boat Onlus (www.pagai-
erosa.org). The cohort included 46 women who were BC 
survivors and 20 healthy subjects. Blood from patients was 
drawn at the Day Hospital of Don Gnocchi Foundation (Rome, 
Italy). BC survivors were divided into three different groups: 
Group A, 17 women who participated in recreational dragon 
boat paddling (mean ± standard deviation age, 53.4±8.8 years); 
group B, 14 women who participated in other recreational 
physical activities (age, 53.9±11.2 years); and group C, 15 seden-
tary women (age, 59.6±9.9 years). The 20 healthy women were 
divided in two groups: Group D, 10 women who participated in 
other recreational physical activities (age, 49.4±7.8 years); and 
group E, 10 sedentary women (age, 51.0±8.1 years) (Table I). 
All the BC survivors were enrolled 10±5 years post-surgery. 
The exclusion criteria included cardiovascular disease, acute 
somatic symptoms, including fever or infection, uncontrolled 
hypertension, uncontrolled pain or any other condition that 
contraindicated exercise training in BC survivors or healthy 
subjects (35). It was not possible to enroll a control group of 
healthy subjects  who participate in dragon boat racing as there 
is only a small number of individuals who play this sport in 
Rome. In addition, the effects of dragon boat mediated-release 
of MMPs in healthy subjects was not part of the scope of the 
present study.
Anthropometric parameters, including height, weight and 
body mass index (BMI), were determined for all participants 
at the beginning of the study (Table I). The TNM status was 
also determined for all the patients (Table II) (36). No clinical 
or radiographic evidence of distant metastases were present.
The present study was performed in accordance with the 
Declaration of Helsinki and written informed consent was 
provided by all subjects prior to enrolling in the study. The 
study was approved by the ethics committee of the Fondazione 
Policlinico Tor Vergata (Study Design DRAGON BOAT-
REGISTRO SPERIMENTAZIONI protocol number 150/13).
Training program. The present study did not involve analysis 
of MMPs prior to training. Thus, the training program did 
not have a specific duration, and patients could be enrolled at 
any time during their training. All subjects from groups A, B 
and D were already performing identical physical activities to 
those described below prior to the start of the study. Sedentary 
subjects were only in groups C and E.
Group A. All subjects in group A participated in recre-
ational dragon boat paddling once a week for 120 min, and 
were supervised by an exercise trainer.
The 120-min dragon boat paddling session included a 
30 min dry land warm up as activation exercise for the whole 
body, followed by 90 min of dragon boat paddling training. The 
dragon boat paddling training consisted of: A 20-min rowing 
warm up on the right and left sides of the boat (changing side 
every 10 min for symmetric training); 50 min rowing with 
stroke-rate regulated by sound feedback (tambourine) and 
rowing technical skill exercises (resting in relation to the 
intensity of the exercise); and 10 min training on competition 
distances (200 or 500 meters repeated at last twice). Finally, 
the subjects performed a 10 min cool-down and 10 min of 
stretching exercises, focusing on the upper limbs.
Groups B and D. All subjects in groups B and D partici-
pated in other recreational physical activities (the same for the 
two groups) 3 times a week for 60 min, and were supervised 
by an exercise trainer.
The 60-min recreational physical activities included 
a 10-min warm-up, 30 min endurance training (treadmill 
6.5-8.0 km/h, cyclette 55-65 rpm or aerobic dance) and 20 min 
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strength training (2-4 kg). The warm up involved large muscle 
groups with low-intensity activities (slow run and execution of 
joint mobility exercises), gradually preparing the body to pass 
from the rest condition to the state of activation, with progres-
sive increase of intensity. Aerobic dance, performed to music, 
was physical exercise that combined rhythmic aerobic exercise 
with strength training routines to improve flexibility, muscular 
strength and cardiovascular fitness. Finally, the subjects 
performed 10 min of stretching exercises. Each subject 
enrolled in groups B and D performed treadmill, cyclette or 
aerobic dance alternately during the week.
Measurement of MMP‑2 and ‑9 levels. Serum samples were 
obtained during the training program. Blood was drawn 
without anticoagulant a total of 48 h after training (and between 
two training sessions) from all subjects between 9:00 and 
10:00 a.m., following an overnight fast, and was allowed to 
coagulate for 20-30 min. Blood samples were not obtained 
before the training program began as the aim of the present 
study was to compare the effects of various physical activities 
on the circulating levels of MMP-2 and MMP-9 in well-trained 
subjects. Serum was separated by centrifugation (800 x g for 
10 min at 4˚C), and all specimens were aliquoted, frozen 
and stored at ‑80˚C within 2 h of collection. Commercially 
available human ELISA kits (high-sensitivity Quantikine; 
catalog nos., MMP200 and DMP900; R&D Systems, Inc., 
Minneapolis, MN, USA) were used to determine the MMP-2 
and -9 levels, according to the manufacturer's instructions. 
Optical density was measured using a microplate reader at a 
wavelength of 450 nm (Model 550; Bio-Rad Laboratories, Inc., 
Hercules, CA, USA).
Statistical analysis. All data were initially entered into a 
Microsoft Excel for Office 2007 database (Microsoft Corpo-
ration, Redmond, WA, USA) and statistical analysis was 
performed using SPSS version 19.0 (IBM SPSS, Armonk, NY, 
USA). Data are presented as the mean ± standard deviation for 
parameters with (normal) Gaussian distributions (following 
confirmation with histograms and the Kolgomorov‑Smirnov 
test) or as frequencies (%) for occurrences.
All data obtained were compared by using one-way 
analysis of variance. Significant results were examined by 
Bonferroni's test for one or more factors, respectively. P<0.05 
was considered to indicate a statistically significant differ-
ence.
To determine the number of samples necessary in each 
group, power analysis was performed based on an α of 5% and 
variation of 40% of the variable outcome MMP-2. The t-test 
showed that an amplitude of n=8 for both groups reached a 
power (1-β) of 94%. This was only calculated for MMP-2 as it 
was the only significantly modified parameter. The variation 
of MMP‑9 concentration was not significant.
Results
No significant differences in age or height were observed 
between the groups. Conversely, the weight (group C vs. group 
E, P=0.024) and BMI (group C vs. group E, P=0.035) were 
significantly higher in sedentary BC survivors in comparison 
with healthy sedentary women (Table I). Table II shows tumor 
stage and lymph node metastasis of breast cancer survivors 
enrolled in the study.
To determine the effect of physical exercise on MMP-2 
and -9 serum concentration in BC survivors and healthy 
subjects, two different exercises training programs were 
compared. The results revealed a difference in MMP serum 
concentration between BC survivors and healthy subjects 
participating in different exercise programs.
Specifically, the MMP‑2 serum concentration was signifi-
cantly increased in the sera of BC survivors participating 
in recreational physical activity (group B) compared with 
those participating in dragon boat paddling (group A; B vs. 
Table I. Anthropometric parameters of enrolled subjects.
 Subject Type of Enrolled Age, Height, Weight, 
Group status physical activity subjects, n yearsa cma kga BMIa
A BC Dragon boat paddling 17 53.4±8.8 161.9±7.5 60.2±9.4 22.9±2.4
B BC Recreational physical activity 14 53.9±11.2 164.2±7.9 64.3±10.2 23.9±3.5
C BC Sedentary 15 59.6±9.9 164.1±5.8 67.4±9.1 25.0±3.3
D H Recreational physical activity 10 49.4±7.8 164.3±2.5 61.6±5.4 22.9±2.4
E H Sedentary 10 51.1±8.1 163.3±4.1 56.3±6.0 21.2±3.0
aMean ± standard deviation. BMI, body mass index; BC, breast cancer; H, healthy.
Table II. Tumor stage and lymph node metastasis of breast 
cancer survivors (n=46).
Parameter Patients, n
Tumor stage
  I 24
  II 14
  III   8
Lymph node metastasis
  Present 25
  Absent 21
Histological type 
  Ductal 42
  Lobular   4
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A, P=0.028), or with sedentary BC survivors (group C; B 
vs. C, P=0.008; Fig. 1A). Statistically significant differences 
were observed between group B (230.7±49.5) and group A 
(184.7±31.7; P=0.028) and between group B and group C 
(182.9±44.8; P=0.008).
However, no significant differences in MMP-2 serum 
concentration were identified between BC patients partici-
pating in dragon boat paddling (group A) and sedentary BC 
survivors (group C; P=0.999). Notably, the mean MMP-2 
serum concentration was significantly higher in BC survi-
vors participating in recreational physical activity (group B, 
230.7±49.5) compared with healthy subjects participating in 
recreational physical activity (group D; 163.8±26.1; P=0.001) 
and between group B and sedentary healthy subjects in 
group E (172.6±25.9; P=0.021). By contrast, no significant 
differences in mean MMP‑2 levels were identified between the 
sedentary BC survivors (group C; 182.9±44.8) and sedentary 
healthy subjects (group E; 172.6±25.9; P=0.999).
The effect of exercise on MMP-9 serum concentration 
revealed a different trend between BC survivors and healthy 
subjects. Notably, physical exercise decreased the MMP-9 
levels in BC survivors in group A and group B compared to 
group C, while it increased the MMP-9 serum levels in healthy 
subjects in group D compared with group E (Fig. 1B).
Although variations in mean MMP‑9 levels were identified 
between dragon boat paddling BC survivors and sedentary BC 
survivors (group A, 99.9±54.5; group C, 169.0±131.2; P=0.679), 
recreational physical activity BC survivors and sedentary 
BC survivors (group B, 114.3±87.8; group C, 169.0±131.2; 
P=0.999), and healthy recreational physical activity and 
healthy sedentary individuals (group D, 93.6.3±58.3; group E, 
67.8±22.5; P=0.999), these differences were not statistically 
significant (Table III).
The association between MMP-2 and -9 serum levels, and 
the presence of lymph node metastasis were also investigated 
in groups A-C. No statistical differences in mean MMP-2 
serum levels were identified between lymph node metastasis 
positive (N+) BC survivors of the dragon boat paddling 
group (group A; 186.5±24.4) and N+ sedentary BC survivors 
(group C; 188.4±45.3) or between the lymph node metastasis 
negative (N-) BC survivors of the dragon boat paddling group 
(group A; 181.5±44.7) and the N- sedentary BC survivors 
(group C; 176.7±46.8) (Fig. 2).
However, significant differences in mean MMP‑2 serum 
levels were identified between N+ BC survivors that partici-
pated in recreational physical activity (group B; 260.7±58.2) 
and N+ sedentary BC survivors (group C; 188.4±45.3; 
P=0.013). No significant differences were identified between 
N- BC survivors participating in recreational physical activity 
(group B; 208.2±28.1) and N- sedentary BC survivors 
(group C; 176.7±46.8; P=0.913). MMP-2 serum levels were 
significantly higher in N+ BC survivors of the recreational 
physical activity group (group B; 260.7±58.2) compared with 
N+ BC survivors of the dragon boat paddling group (group A; 
Table III. Serum matrix metalloproteinase-9 concentration in BC dragon boat group (A), BC physical activity group (B), BC 
sedentary group (C), H physical activity group (D) and H sedentary group (E).
Dragon boat/physical activity group (mean ± sd) Sedentary group (mean ± sd) P-value
A (99.9±54.5) C (160.9±131.2) 0.679
B (114.3 ± 87.8) C (160.9±131.2) 0.999
D (93.6 ± 58.3) E (67.8 ± 22.5) 0.999
BC, breast cancer; H, healthy; sd, standard deviation.
Figure 1. MMP‑2 and MMP‑9 serum concentration in breast cancer survivors and healthy subjects. (A) Significant differences in MMP‑2 levels were identified 
in group B when compared with groups A (P=0.028), C (P=0.008), D (P=0.001) and E (P=0.02). *P<0.05 vs. B. (B) No significant differences in MMP‑9 levels 
were identified between groups A‑E. MMP, matrix metalloproteinase.
  A   B
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186.5±24.4; P=0.007) (Fig. 2). No significant differences were 
observed in MMP-9 serum levels between the N- and N+ 
subgroups among groups A-C.
Discussion
Regular physical exercise improves physical function, quality 
of life and reduces fatigue in BC survivors (37,38). It also 
decreases the risk of BC recurrence and reduces BC‑specific 
mortality in BC survivors (39,40).
Physical exercise is considered an essential factor for 
improving cancer survival. Previous studies have indicated 
that exercise interventions are efficacious in men with prostate 
cancer (41,42) and in multiple myeloma (43,44). In endometrial, 
ovarian and colorectal cancer survivors, lifestyle interventions 
that include regular participation in physical activity are asso-
ciated with positive health outcomes (45,46). Furthermore, it 
has been demonstrated that individuals who are physically 
active after being diagnosed with breast or colon cancer 
exhibit a higher rate of survival compared with those that are 
physically inactive (47).
Circulating MMPs are involved in the breakdown of the 
ECM in carcinogenesis and cardiovascular diseases (48). 
MMPs modulate the activation of growth factors, cytokines 
and angiogenesis, facilitating physiological adaptations to 
exercise (18,49).
However, high levels of mechanical stress, such as that 
induced by high physical impact exercise, may activate the local 
production of MMPs in skeletal muscle. Rullman et al (50) 
reported that a single session of exercise induces MMP-9 
activation, causing a marked increase in serum MMP-9 
concentration. Kadoglou et al (24) demonstrated that exer-
cise reduces MMP-9 serum levels, but not MMP-2 levels, in 
patients with type 2 diabetes. Additional studies have inves-
tigated the function of circulating MMP-2 and MMP-9 in BC 
patients (51,52); the results revealed increased MMP-9 expres-
sion and activity in malignant tumors, and enhanced MMP-2 
activity in malignant tumors exhibiting high estrogen receptor 
expression. These studies indicate that serum levels of MMP-2 
or -9 may present useful markers for the staging and prognosis 
of BC and other types of cancer (53), such as prostate adeno-
carcinoma, in association with prostate‑specific antigen levels, 
gastric cancer and lung carcinoma (54-56).
At present, the effect of different exercise training 
programs on MMP-9 and -2 serum levels in human subjects 
remains unclear (57). It was previously demonstrated that 
endurance training decreases MMP-9 concentration (58) and 
aerobic training reduces MMP-2 plasma levels in individuals 
with pathological conditions (25). Urso et al (26) observed 
that the variation in MMP-2 and -9 serum levels is dependent 
on different exercise training regimens. Thus, understanding 
which type of exercise and intensity may reduce the risk of 
recurrence in BC patients is important.
The aim of the present study was to determine the effect of 
two different exercise training programs on the serum MMP-2 
and -9 levels of healthy subjects and BC survivors. The results 
did not identify any significant differences in MMP‑2 serum 
levels in healthy subjects that participated in recreational 
physical activity; there were no significant differences in 
MMP-2 serum levels in group D compared with group E, and 
although MMP-9 levels increased in group D compared with 
group E, these differences were not statistically significant. 
Among the BC survivors, no significant differences in circu-
lating MMP‑2 levels were identified between the dragon boat 
paddling (group A) and sedentary (group C) groups. However, a 
significant increase in serum MMP‑2 was identified in the recre-
ational physical activity BC group (group B) compared with the 
sedentary BC group (group C). This difference in circulating 
MMP-2 levels following exercise appears to be dependent on 
the different exercise training programs undertaken by the BC 
survivors; however, the same exercise program did not induce 
significant increases in the MMP-2 levels of healthy subjects.
MMP-9 serum levels were higher in sedentary BC survi-
vors (group C) than in healthy subjects (group E). Furthermore, 
MMP-9 serum levels were decreased in both groups of recre-
ationally active BC survivors (groups A and B) compared with 
sedentary BC survivors (group C). This result may be asso-
ciated with tumor necrosis factor-α (TNF-α) expression, as 
TNF-α is a stimulator of MMP-9 production and is decreased 
following exercise (59,60).
Figure 2. MMP‑2 and MMP‑9 serum levels in N+ and N‑ breast cancer survivors. (A) Significant differences in MMP‑2 levels were identified in the BN+ group 
when compared with the CN+ (P=0.013) and AN+ (P=0.007) groups. *P<0.05 vs. N‑ group. (B) No significant differences in MMP‑9 levels were identified between 
groups A-C. Number of survivors: Group A, N- 6; N+ 11; group B, N- 8; N+ 6; group C, N- 7; N+ 8. MMP, matrix metalloproteinase; N+, lymph node metastasis 
positive; N-, lymph node metastasis negative.
  A   B
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However, exercise increased MMP-9 serum levels in the 
healthy subjects (group D vs. E). This difference reflects the 
impact of exercise training and may be associated with an 
inflammatory response (61). Rullman et al (62) reported that 
endurance exercise enhances MMP-9 but not MMP-2 levels in 
human skeletal muscle in healthy subjects.
Our previous study regarding exercise in BC patients 
contributed to the understanding of the modulatory effects of 
exercise on MMP-2 and MMP-9 regulation. It was demonstrated 
that muscle-derived cytokines are released following a training 
program, while decreasing the oxidative stress (14). Changes 
in MMP serum levels may reflect the impact of exercise on the 
production of inflammatory molecules. It is hypothesized that 
exercise causes a reduction in free radicals and an increase in 
antioxidant defenses, which may influence the inflammatory 
conditions and subsequently alter MMP serum concentrations. 
The different effects of exercise observed on MMP-2 and -9 
serum levels may be associated with different dose-dependent 
responses to physical activity (57).
The results of the present study indicate that the type of 
physical exercise (intensity, volume, frequency and length) 
may effect MMP-2 and MMP-9 plasma levels. The effect of the 
same exercise program was different in healthy subjects and 
BC survivors. To the best of our knowledge, it remains to be 
elucidated why this differential response occurs. To understand 
these findings, it is helpful to analyze the weekly frequency of 
exercise, as well as the period of rest and the muscle strength 
applied. In the present study, exercise was performed once a 
week for 120 min with a rest time of 6 days in the dragon 
boat paddling group (group A). The muscle strength applied 
during paddling is proportionate to an anti-gravity exercise in 
accordance with the variables of hydrodynamics. The other 
recreational physical activity groups (group B and D) trained 
3 times a week for 60 min, and thus the rest time was shorter 
than that of the dragon boat paddling group. For groups B 
and D, the muscle strength applied was proportionate to the 
extra load used during the exercise session without the benefit 
of hypogravity. All these variables have been shown to affect 
MMP-2 serum levels in BC survivors.
Coagulation enzymes are involved in MMP-2 activation 
for example, urokinase plasminogen converts plasminogen 
to plasmin, which promotes tumor growth and angiogenesis, 
degrading the ECM and basement membrane, and activating 
pro-MMPs (63). MMPs and urokinase plasminogen activators 
are involved in tumor invasion and metastasis. The results of the 
present study demonstrated that BC survivors exhibit increased 
MMP-2 levels when compared with healthy subjects. These 
results may be due to an increase in urokinase plasminogen 
activator expression, as it has been demonstrated that exercise 
increases plasma fibrinolytic activity. Furthermore, exhaustive 
exercise is associated with increased expression of plasminogen 
activator in plasma (64), and exercise-stimulated thrombin and 
plasmin generation were previously identified in healthy subjects 
that exercised for a significantly longer duration (65). Prolonged 
physical exercise is associated with numerous changes in blood 
hemostasis and higher levels of aerobic fitness are associated 
with increased fibrinolytic activity (66,67), while MMP‑2 acti-
vation is inhibited by plasmin inhibitors (68).
Previous studies have reported that serum levels of 
MMP‑2 and MMP‑9 are significantly higher in BC patients 
than in control subjects (69,70). Furthermore, patients with 
N+ cancer exhibit significantly higher MMP‑2 and MMP‑9 
activity than those with N- cancer (53). The results obtained 
in the present study revealed a significant increase in MMP‑2 
but not MMP-9 concentration in N+ BC survivors compared 
with N- BC survivors. Furthermore, different exercise 
regimes exhibited different effects on circulating MMP-2 
and MMP-9 levels.
In conclusion, the contradictory results obtained in the 
present study may be due to the fact that exercise of various 
intensities were performed in previous studies. Therefore, 
further studies are required to determine the biological signifi-
cance of MMP levels in the adaptation of skeletal muscle to 
physical activity in cancer patients and to explore how different 
types of physical exercise affect MMP production. Overall, 
the results of the present study indicate that various physical 
activities modulate the levels of circulating MMP-2 and -9 
in BC survivors, and an identical exercise program induces 
a contrasting effect when undertaken by healthy subjects and 
BC survivors.
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